We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current RKAGY market cap is 809.96M. The company's latest EPS is EUR 0.2892 and P/E is 44.61.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.53B | 1.57B | 1.6B | 1.67B | 1.74B |
| Operating Income | 57.14M | 10.8M | 30.92M | 36.36M | 41.08M |
| Net Income | 43.42M | 1.45M | 28.3M | 25.14M | 38.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 1.63B | 1.63B | 1.67B | 1.7B | 1.77B |
| Total Liabilities | 446.11M | 439.45M | 440.82M | 453.51M | 490.3M |
| Total Equity | 1.19B | 1.19B | 1.22B | 1.25B | 1.28B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 47.3M | 113.3M | 97.5M | 41.3M | 109M |
| Investing | -86.7M | -135.2M | -58.3M | -86.2M | 40.9M |
| Financing | 35.1M | -15.1M | -3.9M | -4.1M | -21.2M |
| Market Cap | 809.96M |
| Price to Earnings Ratio | 44.61 |
| Price to Sales Ratio | 0.99 |
| Price to Cash Ratio | 8.38 |
| Price to Book Ratio | 1.35 |
| Dividend Yield | - |
| Shares Outstanding | 133.88M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 1.73% |
| 52 Week High | 6.51 |
| 52 Week Low | 5.41 |
| Spread (Intraday) | 3.64 (49.52%) |
| Company Name | Rhoen Klinikum AG (PK) |
| Address |
schlossplatz 1 bad neustadt an der saale 97616 |
| Website | https://www.rhoen-klinikum-ag.com |
| Industry | health care facilities diverse (H1) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
